Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

    This grant seeks research to understand mood and psychosis disorders arising during menopause, focusing on neurobiology, hormones, and psychosocial factors to identify treatment targets.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

    This grant supports developing and testing innovative psychosocial interventions for mental disorders to accelerate translating research into therapies.

    HHS-NIH11Due Feb 17, 2027

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

    Research grant to develop and test new psychosocial interventions for mental disorders, with focus on experimental therapeutics to translate basic science into treatments.

    HHS-NIH11Due Feb 17, 2027

    Women's Health Information for Grant Submissions

    Bayer funds educational programs for healthcare professionals on menopause symptom management, emphasizing neurokinin-targeted therapies and the KNDy system’s role in vasomotor symptoms.

    BayerRolling submissions

    Menopause, Treatment Guidelines, and Breast Cancer

    This grant funds research on menopause, treatment guidelines, and breast cancer to inform California health policy and ensure equitable, evidence-based care through strong community engagement.

    CBCRPDue Oct 29, 2026· 3d$200,000

    Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

    Funding for early testing of new drug or device treatments for mental disorders to understand mechanisms and assess clinical effects.

    HHS-NIH11Due Feb 17, 2027